Vitiligo Clinical Trial: Autoimmune Study
Vitiligo Clinical Trail: Autoimmune Study
Role Of Immunosuppressive Cells In The Development Of Vitiligo
Henry Ford Department of Dermatology,
3031 West Grand Boulevard Detroit, MI 48202
Patients with vitiligo often have either a personal or family history of other
autoimmune conditions. This association may be due to a common underlying
immune mediated mechanism. As humans have an active immune system to fight
off infections and viruses, a check-and-balance system exists to keep the immune system from attacking your own cells. When the immune system attacks the body’s own cells, we call this an autoimmune condition. In our study, we are trying to assess the role of regulatory cells for the immune system in the development of vitiligo. Ultimately, the goal of this research is to find new therapeutic strategies for autoimmune vitiligo to stop an ongoing immune attack on pigment cells in active vitiligo
Ages: 18-89 years of age
Diagnosis of generalized vitiligo
No personal or family history of other autoimmune conditions is required.
Exclusion Criteria: The following will not be eligible:
Women who are lactating, pregnant or planning to become pregnant
What will happen if I participate?
Demographic (age, gender, ethnicity) and medical history will be collected.
A small sample of blood will be collected in the same way that blood is drawn at your regular doctor’s office.
To participate, or for more information: Contact: Dr. Tasneem Mohammad
Phone: 313-916-6964 or Email: email@example.com
Information found here